Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Board Meeting Outcome

JHS Svendgaard Laboratories Board Meeting Outcome

JHS Svendgaard Laboratories' board approved variations in using preferential issue proceeds. Total funds of ₹3.00 Crore will be redeployed for capital expenditure and growth.

Key figures
Value₹3.00 Cr
Source

BSE filing, NSE: JHS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

JHS Svendgaard Laboratories Ltd: key numbers

Share price
₹8.19
Market cap
₹70.11 Cr
Revenue (annual)
₹101.7 Cr
Net profit (annual)
₹-1.92 Cr
P/E (TTM)
-37.2×Sector 39.0×
Promoter holding
33.85%+0.00% QoQ
FII holding
2.87%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from JHS Svendgaard Laboratories Ltd

All →

Other board meeting outcome announcements

All →